Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis.
FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma.
Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis.
Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Erratum.
Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
Any evident MRI T2-lesion activity should guide change of therapy in multiple sclerosis - Yes.
Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
Consensus guidelines for the diagnosis and treatment of multiple sclerosis.
Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.
The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ): development of a shortened scale.
Role of microglia in CNS autoimmunity.
The relation between peptide hormones and sex hormone in patients with multiple sclerosis.
Multiple sclerosis impairs regional functional connectivity in the cerebellum.
Viruses and Multiple Sclerosis.
Going Against the Tide - How Encephalitogenic T Cells Breach the Blood-Brain Barrier.
Pattern of Uveitis in an Egyptian Population with Multiple Sclerosis: A Hospital-Based Study.
Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study.
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.
Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study.
Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress.
Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis.

Pages